Georgetown University

Immune checkpoint inhibitor therapy appeared to be a safe, effective treatment for patients with advanced-stage cancer and HIV infection, according to a systematic review published in JAMA Oncology.

Bifurcation lesions continue to pose many challenges to successful PCI and optimal outcomes. Multiple strategies and techniques have been described. Now, there is a new OCT-guided technique that could improve how a stent is implanted during PCI for bifurcation lesions.

Modeling and simulation are valuable research and product development tools that are helping to advance regulatory science, according to the FDA.

Combination therapy with axitinib plus pembrolizumab appeared promising and tolerable among patients with advanced renal cell carcinoma, according to findings from an ongoing open-label phase 1b trial.

The opioid epidemic in the United States has affected millions, exposing them to health risks that include a range of infectious diseases.

According to an interim analysis from a registry presented at VIVA 17, a drug-coated balloon was safe and effective at 12 months.

Rectal and left-sided colon cancers are not clearly delineated by location but rather are characterized by a range of distinct molecular variations, a phenomenon that has implications for developing tailored treatments in the future, according to data presented at the Gastrointestinal Cancers Symposium.

Adults in lower income brackets who have diabetes and a high-deductible insurance plan had fewer primary care, checkup and specialty visits vs. those with no deductible, according to a secondary analysis of Medical Expenditure Panel Survey data.

Results of a Reuters/Ipsos poll taken during Nov. 9-14, 2016 indicated more than 20% of Americans wanted President-elect Donald J. Trump to focus on health care in his first 100 days in office. However, when Healio Rheumatology reached out to members of the clinical community for commentary on what could realistically be accomplished, there were more questions than answers.

The use of vaporized nicotine products, such as e-cigarettes, projected a reduction in the number of smoking-related deaths by 21% when compared with a scenario without e-cigarettes in which smokers used traditional tobacco products, according to a modeling study.